| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.0M | +29.7% |
| Cost of Revenue | $15.8M | +6.1% |
| Gross Profit | $19.1M | +59.0% |
| R&D Expense | $0 | — |
| SG&A Expense | $11.6M | +3.4% |
| Operating Income | $6.1M | +853.9% |
| Pre-tax Income | $5.8M | +8318.6% |
| Net Income | $5.8M | +7126.6% |
| EPS (Basic) | $0.01 | — |
| EPS (Diluted) | $0.01 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -28.7% |
| Accounts Receivable | $188K | +653.7% |
| Current Assets | $55.7M | +56.5% |
| Total Assets | $63.8M | +52.4% |
| Current Liabilities | $40.8M | +54.1% |
| Total Liabilities | $41.4M | +51.0% |
| Stockholders' Equity | $22.4M | +55.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.0M | -466.4% |
| Investing Cash Flow | $2.1M | +365.3% |
| Financing Cash Flow | $31.2M | — |